Presented to you through Paradigm Publishing Services
Columbia University Press
Chapter
Licensed
Unlicensed
Requires Authentication
11. PATENT OPINIONS
You are currently not able to access this content.
You are currently not able to access this content.
Chapters in this book
- Frontmatter i
- CONTENTS v
- PREFACE xiii
- INTRODUCTION 1
-
SECTION I: PATENT LAW
- 1. THE PATENT AS A NEGATIVE RIGHT AND THE CLAIM AS ITS BUSINESS END 13
- 2. CONSTRUING THE PATENT CLAIM 24
- 3. THE PATENTABLE INVENTION 29
- 4. THE PATENT DOCUMENT’S ROLE IN SUPPORTING A CLAIMED INVENTION 49
- 5. THE LONG ROAD TO GETTING A PATENT 57
- 6. LENGTHENING AND SHORTENING A PATENT’S TERM 70
- 7. CONTINUING-APPLICATION PRACTICE AND THE MAKING OF A PATENT FAMILY 78
- 8. THE MURKY WORLD OF INVENTORSHIP 89
- 9. PATENT INFRINGEMENT AND ITS VARIATIONS 101
- 10. DEFENSES AND PREEMPTIVE CHALLENGES 116
- 11. PATENT OPINIONS 129
- 13. THE INTERPLAY BETWEEN TRADE SECRETS AND PATENTS 151
-
SECTION II: REGULATORY LAW
- 14. THE INNOVATOR DRUG: FROM DEVELOPMENT TO APPROVAL 163
- 15. GENERIC DRUGS 180
- 16. BIOSIMILARS 207
-
SECTION III: CONTRACT LAW
- 17. THE CONTRACT: AN ENFORCEABLE PROMISE 225
- 18. BIOTECHNOLOGY AGREEMENTS 242
- ACKNOWLEDGMENTS 283
- FURTHER READING 285
- GLOSSARY OF LEGAL ACRONYMS AND ABBREVIATIONS 295
- INDEX 297
Chapters in this book
- Frontmatter i
- CONTENTS v
- PREFACE xiii
- INTRODUCTION 1
-
SECTION I: PATENT LAW
- 1. THE PATENT AS A NEGATIVE RIGHT AND THE CLAIM AS ITS BUSINESS END 13
- 2. CONSTRUING THE PATENT CLAIM 24
- 3. THE PATENTABLE INVENTION 29
- 4. THE PATENT DOCUMENT’S ROLE IN SUPPORTING A CLAIMED INVENTION 49
- 5. THE LONG ROAD TO GETTING A PATENT 57
- 6. LENGTHENING AND SHORTENING A PATENT’S TERM 70
- 7. CONTINUING-APPLICATION PRACTICE AND THE MAKING OF A PATENT FAMILY 78
- 8. THE MURKY WORLD OF INVENTORSHIP 89
- 9. PATENT INFRINGEMENT AND ITS VARIATIONS 101
- 10. DEFENSES AND PREEMPTIVE CHALLENGES 116
- 11. PATENT OPINIONS 129
- 13. THE INTERPLAY BETWEEN TRADE SECRETS AND PATENTS 151
-
SECTION II: REGULATORY LAW
- 14. THE INNOVATOR DRUG: FROM DEVELOPMENT TO APPROVAL 163
- 15. GENERIC DRUGS 180
- 16. BIOSIMILARS 207
-
SECTION III: CONTRACT LAW
- 17. THE CONTRACT: AN ENFORCEABLE PROMISE 225
- 18. BIOTECHNOLOGY AGREEMENTS 242
- ACKNOWLEDGMENTS 283
- FURTHER READING 285
- GLOSSARY OF LEGAL ACRONYMS AND ABBREVIATIONS 295
- INDEX 297